SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1160Maybe for underwriter?Miljenko Zuanic-11/13/2006
1159From: uccc.info “Tumor tissue from animals treated with VEGF Trap had elevated Miljenko Zuanic-11/13/2006
1158Regeneron Announces Common Stock Public Offering Monday November 13, 5:47 pm ET dr.praveen-11/13/2006
1157<i>Moreover, mice treated with VEGF-TRAP also demonstrated a marked elevatBiomaven-11/13/2006
1156Doc P..Many thanks for these updates here and the other threads..Elisabethzeta1961-11/12/2006
1155Upcoming milestones: IL-1 Trap - Ph IIa preliminary data in SJIA ACR (Nov. 10-1dr.praveen-11/12/2006
11541987] VEGF-TRAP Exhibits Potent In Vivo Anti-Tumor Activity in Acute Myeloid LeuMiljenko Zuanic-11/10/2006
1153No idea, no complain. Two nice deals, possibility for good market opportunity, Miljenko Zuanic-11/7/2006
1152Wondering what's suddenly driving the price up since the last few days...I&#dr.praveen-11/7/2006
1151Current Business Highlights(From the C/C) In the third quarter of 2006, Regenerdr.praveen-11/6/2006
1150Every time I think about REGN, my gut says to continue accumulating even at theszeta1961-11/3/2006
1149What piss me off is that food processing ing.(Rupp) exercise his options that eMiljenko Zuanic-11/2/2006
1148Add to that, they will also be manufacturing some serious new Humab's on thedr.praveen-11/2/2006
1147Answer: Message 22712188 And, yes they need to recapture ~$150M manufacturing cMiljenko Zuanic-11/2/2006
1146It's not serious science. IL-1 trap was supposed to be a more potent versionrkrw-11/2/2006
1145rkrw, haven't you figured out by now that any serious question about the scitom pope-11/2/2006
1144Makes me wonder if kineret is used or will be used in CAPS instead of il-1 trap rkrw-11/2/2006
1143Manufacturing (Rupp) and Clinician (Stahl) are cashing out options (rule 10b5-1)Miljenko Zuanic-11/2/2006
1142Thx for the notes.kenhott-10/31/2006
1141Merrill unimpressed: Positive phase III results in CAPS REGN reported positive tom pope-10/31/2006
1140lehman; target price = 33 REGN reported late yesterday positive phase III data software salesperson-10/31/2006
1139Nice data on the IL-1 trap. My notes read patient populations in the hundreds. kenhott-10/31/2006
1138Thanxs Jim. You should take Rupp for a drink. (Schleifer is probably hard "Miljenko Zuanic-10/30/2006
1137<I know what I will do!> Me to, but one can never be sure what to expect Biotech Jim-10/30/2006
1136The results are as expected,,,,, very good. Maybe investors (and me) will startMiljenko Zuanic-10/30/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News